United States · FDA National Drug Code directory
Hydromorphone Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 13811-703_e22a1e07-ff84-4ef1-b154-804b49dcd52f
- Product NDC
- 13811-703
- Form
- TABLET, EXTENDED RELEASE
- Composition / generic term
- Hydromorphone Hydrochloride
- Labeler
- Trigen Laboratories, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20160915
- Source listing expiry
- 20261231
Source-listed ingredients
- HYDROMORPHONE HYDROCHLORIDE — 16 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (13811-703-10) · 13811-703-10
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →